OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
October 29, 2020
Two FDA-funded projects at RCPE will look at real-time monitoring and control of drug tablet coating and developing a digital twin for drug production control.
October 27, 2020
The Phase III clinical trial of NVX-CoV2373 is expected to be fully enrolled in the UK and will begin in the US and Mexico by the end of November 2020.
September 25, 2020
A clinical trial to enroll up to 10,000 volunteers across the UK will assess whether NVX-CoV2373 is effective in the prevention of COVID-19.
September 24, 2020
UK's Prime Minister visited the site of the country’s VMIC in Oxfordshire, and met the teams working at the forefront of the national COVID-19 response.
September 23, 2020
A Phase III trial to evaluate safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S, is enrolling participants on three continents.
September 17, 2020
The Russian Direct Investment Fund has announced three deals with India, Brazil, and Mexico, for the supply of doses of Sputnik V, a potential COVID-19 vaccine.
September 16, 2020
Polymeric containers offer an alternative to glass.
September 13, 2020
Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.
September 08, 2020
The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.
As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.
September 03, 2020
Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain.
Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.
A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.
September 02, 2020
End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.
Early adopters and equipment manufacturers refine their equipment and processes, paving the way for broader use.
August 24, 2020
Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.
August 20, 2020
EC finalizes agreement to purchase millions of doses of AstraZeneca's COVID-19 vaccine.
CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.
Novavax has signed an agreement with the UK government for 60 million doses of a COVID-19 vaccine and a Phase III clinical trial.
August 19, 2020
Plastic primary packaging could help prevent supply chain shortages associated with high demand for COVID-19 vaccines.